World Patient Safety Day; 17th September

Dear Colleagues,
Greetings. Congratulations to each and every one of us on the phenomenal success of World Patient Safety Day 2022, dedicated to the theme of “Medication Safety”!
The members of this Global Patient Safety Network are and have been the driving force behind this outstanding achievement. Thank you for leading and uniting for the cause and for showing your commitment to “Medication Without Harm”. I am delighted to share that the response has been spectacular and extremely impressive. We have received inspiring reports from regions, countries and partners where a wide range of activities and events have been organized. Lighting up of landmark monuments, and iconic buildings in ‘orange’ has become a ‘living symbol’ of World Patient Safety Day year after year and the global solidarity it demonstrates. We encourage colleagues who have not shared the story of their events to please post them on GPSN or via the following e-survey available on the WPSD 2022 campaign page. We are working on a summary report illustrating all these amazing contributions.
On 15 September, WHO headquarters organized a global virtual event Medication Without Harm” with interpretation in eight languages. There were 5191 registrants from around 165 countries across all WHO regions for the event, and it was attended by 1508 participants from 122 countries. The event structured around the strategic framework of the WHO Global Patient Safety Challenge: Medication Without Harm, featured presentations and a panel discussion by global patient safety leaders, medication safety experts and patient advocates. Recordings of this event will be made available soon on the Event’s page.
WHO also issued a News release to raise awareness of the media and the general public on the need to prioritize and address medication safety. In addition to the diversity of communication products, you can view the Director-General of WHO video message here and the Campaign video here.
During this year-long campaign, Patient Safety Flagship will be working with experts and partners to develop a series of Medication Safety Solutions (MSSs), among other technical products aimed at addressing medication safety in priority areas, with high burden of patient harm. Please note that Policy brief: Medication Without Harm; Systematic review: Global burden of medicationrelatedharm; and MSSs – Medication safety in maternal and newborn care; and Medication safety for look-alike and sound-alike medicines will be published in the near future.
On behalf of the WHO Patient Safety Flagship, I would like to extend our deep appreciation and gratitude to all of you. Please do share your stories and amplify the messages of this year’s campaign. Know. Check. Ask.
Looking forward to strengthening the work on Medication Without Harm and maximize the impact of World Patient Safety Day 2022.
Thanks and best regards,
Unit Head
WHO Patient Safety Flagship/
A Decade of Patient Safety 2021-2030
World Health Organization
Geneva, Switzerland 
Office: +41 22 791 4660   


What’s coming?

As the partnership with SmartMed has been materialized the focus has gone to identifying potential international locations where Medication Safety Trainings (with the use of the SmartMed software Farmasys 6.0) can be held for students.

At this moment 2 locations are worked on: Rwanda & Mongolia.

To be continued.

Back on Track!

For quite a while a somewhat dormant condition has been applicable. Covid-19 certainly also played a roll.

But now: happy to announce that we are Back on Track!

In the near future we can tell more about exiting news!


EPN biennial forum 2018 in Kampala

In Kampala (Uganda), from 15th-18th May 2018, the Ecumenical Pharmaceutical Network (EPN) biennial forum was held.

The theme of this forum meeting was Medication Safety.

As a member of EPN GIMS was represented by it’s chairman and performed as a speaker, did a poster presentation about the GIMS model and contributed with 3 articles in the EPN electronic magazine Pharmalink.

Valuable contacts were made and follow up activities are investigated.

Link to the articles:

EPN-Poster-GIMS Kampala 2018

GIMS model article EPN forum 2018 v1

EPN article medication safety medication programs

EPN article Sellin-Vanslobbe


Tokyo declaration on Patient Safety

On the 14th till 17th of April 2018 a high level meeting took place in Tokyo.

“The Tokyo Declaration on Patient Safety is founded on the policies articulated in World Health Assembly resolution WHA55.18 (2002), which urged Member States to “pay the closest possible attention to the problem of patient safety and establish and strengthen science-based systems, necessary for improving patient safety and the quality of health care”.

“Recognizing that patient safety is one of the most important components of health care delivery which is essential to achieve Universal Health Coverage (UHC), and moving towards UN Sustainable Development Goals (SDGs); and that patient safety systems and practices need to be established in all countries as one of the critical health care standards for achieving UHC on a sustainable basis;” 

GIMS wants to/can contribute through developing and implementing pharmaceutical IT-tools.

Whole text of Tokyo declaration:  Tokyo declaration

GIMS at EPN biennial forum in Kampala

The Ecumenical Pharmaceutical Network ( is having it’s biennial forum in Kampala from 15-18 May this year.

The theme will be; ‘ Patient safety, Medication without Harm’.

GIMS foundation will be present and will contribute through a poster presentation and a scientific article about the ‘Gims Model for Screening and Rating of Medication Safety in a Country’.

Medication Safety in donor-sponsored public health programs

As known there are huge sponsored medication access programs by diverse organizations. The Global Fund is one them. In the last decade enormous amounts of medicines (specifically against HIV, TB, Malaria) have been distributed

But has there been attention for the Medication Safety aspect as well??

In the article beneath a first attempt to get more insight.

Medication Safety in donor-sponsored public health programmes